Statements (31)
| Predicate | Object |
|---|---|
| gptkbp:instanceOf |
gptkb:drug
|
| gptkbp:approvedBy |
1957
|
| gptkbp:ATCCode |
M03BA03
|
| gptkbp:availableOn |
gptkb:tablet
injectable solution |
| gptkbp:contraindication |
hypersensitivity to methocarbamol
|
| gptkbp:drugClass |
muscle relaxant
|
| gptkbp:eliminationHalfLife |
1-2 hours
|
| gptkbp:excretion |
urine
|
| gptkbp:genericName |
gptkb:methocarbamol
|
| https://www.w3.org/2000/01/rdf-schema#label |
Robaxin
|
| gptkbp:interactsWith |
gptkb:beer
gptkb:CNS_depressants |
| gptkbp:legalStatus |
prescription only
|
| gptkbp:manufacturer |
gptkb:Pfizer
|
| gptkbp:mechanismOfAction |
central muscle relaxant
|
| gptkbp:metabolism |
liver
|
| gptkbp:overdoseSymptoms |
seizures
CNS depression |
| gptkbp:pregnancyCategory |
C
|
| gptkbp:prescribes |
musculoskeletal pain
tetanus adjunct |
| gptkbp:routeOfAdministration |
oral
intravenous |
| gptkbp:sideEffect |
nausea
vomiting dizziness drowsiness |
| gptkbp:usedFor |
muscle spasms
|
| gptkbp:bfsParent |
gptkb:methocarbamol
|
| gptkbp:bfsLayer |
8
|